OverviewSuggest Edit

PathAI is a company developing an AI-based platform technology for data-driven pathology analysis. It provides research and drug development, clinical, and global health solutions. The platform helps to deliver standardized pathologic diagnoses.
TypePrivate
Founded2016
HQBoston, MA, US
Websitepathai.com
Employee Ratings4.6

Latest Updates

Employees (est.) (Jun 2021)211(+9%)

Key People/Management at PathAI

Andrew H. Beck

Andrew H. Beck

Co-Founder & CEO
Aditya Khosla

Aditya Khosla

Co-Founder & CTO
Andy Moffit

Andy Moffit

Chief People Officer
Liz Storti

Liz Storti

VP of Finance and Operations
Joe Adu

Joe Adu

Director of Information Technology and Security
Don O'Neill

Don O'Neill

VP of Engineering
Show more

PathAI Office Locations

PathAI has offices in Boston and Austin
Boston, MA, US (HQ)
120 Brookline Ave
Austin, TX, US
316 W 12th St 6th Floor
Show all (2)

PathAI Financials and Metrics

Summary Metrics

Founding Date

2016

PathAI total Funding

$255.2 m

PathAI latest funding size

$165 m

Time since last funding

a month ago

PathAI investors

PathAI's latest funding round in May 2021 was reported to be $165 m. In total, PathAI has raised $255.2 m
Show all financial metrics

PathAI Operating Metrics

Sep, 2020

Patents (US)

2
Show all operating metrics

PathAI Online and Social Media Presence

Embed Graph

PathAI Company Culture

  • Compensation

    A+

    100/100

Learn more on Comparably

PathAI News and Updates

PathAI grabs $75 mln Series B

Boston-based PathAI, a provider of AI-powered research tools and services for pathology, has raised $75 million in Series B funding. The investors include Merck Global Health Innovation Fund and Bristol-Myers Squibb.

PathAI raises $60 million for AI pathology and diagnostic tools

PathAI, a startup developing a tool set that applies AI to pathology images, has raised $60 million in fresh venture capital.

PathAI Secures $60M in Series B Funding Led by General Atlantic and Existing Investor General Catalyst

Boston, MA — April 17, 2019 — PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by new investor General Atlantic, a leading global growth equity firm, with strong participation …

PathAI Frequently Asked Questions

  • When was PathAI founded?

    PathAI was founded in 2016.

  • Who are PathAI key executives?

    PathAI's key executives are Andrew H. Beck, Aditya Khosla and Andy Moffit.

  • How many employees does PathAI have?

    PathAI has 211 employees.

  • Who are PathAI competitors?

    Competitors of PathAI include Tempus, Prognos Health and HealthCode AI.

  • Where is PathAI headquarters?

    PathAI headquarters is located at 120 Brookline Ave, Boston.

  • Where are PathAI offices?

    PathAI has offices in Boston and Austin.

  • How many offices does PathAI have?

    PathAI has 2 offices.